检索历史清除

首页> The American journal of managed care> Eligibility Varies Among the 4 Sodium-Glucose Cotransporter-2 Inhibitor Cardiovascular Outcomes Trials: Implications for the General Type 2 Diabetes US Population

Eligibility Varies Among the 4 Sodium-Glucose Cotransporter-2 Inhibitor Cardiovascular Outcomes Trials: Implications for the General Type 2 Diabetes US Population

导出原文传递

翻译打印收藏纠错

作者： Wittbrodt, Eric T. ^[1] ; Eudicone, James M. ^[2] ; Bell, Kelly F. ^[3] ; Enhoffer, Devin M. ; Latham, Keith ; Green, Jennifer B.

作者单位： Rutgers State Univ, Piscataway, NJ USA ^[1] Duke Univ, Med Ctr, Div Endocrinol, Durham, NC USA ^[2] AstraZeneca, Wilmington, DE 19803 USA ^[3]

发布时间 2020-07-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交